| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:5000 |
| IHC | 1:50-1:200 |
| FC | 1:50-1:200 |
Dihydrolipoamide acetyltransferase, encoded by the DLAT gene, serves as the E2 component of the pyruvate dehydrogenase complex, a critical mitochondrial enzyme system that links glycolysis to the citric acid cycle. This protein has garnered significant research attention due to its role as the 70 kDa mitochondrial autoantigen in primary biliary cirrhosis, making it a valuable target for both metabolic studies and autoimmune disease research.
This recombinant rabbit monoclonal antibody, clone 5C6, offers researchers the reproducibility and consistency that comes with sequence-defined production. Unlike traditional hybridoma-derived antibodies, recombinant technology ensures that every lot performs identically, eliminating the variability that can complicate long-term studies or multi-site collaborations.
Extensive validation demonstrates this antibody's versatility across multiple experimental platforms. Western blot analysis confirms specific detection at the expected 69 kDa molecular weight across a diverse panel of human cell lines including HepG2, K562, COLO205, MCF7, Jurkat, A549, PC-3, and U251, as well as mouse brain tissue, supporting the stated cross-species reactivity with human and mouse samples. Immunohistochemistry validation in paraffin-embedded human kidney and liver cancer tissues shows reliable staining with citrate buffer antigen retrieval, while flow cytometry analysis in MCF-7 cells demonstrates clear positive signal separation from isotype controls.
The antibody arrives in a stabilized liquid format containing glycerol for convenient aliquoting and long-term storage. Whether investigating mitochondrial metabolism, pyruvate dehydrogenase complex function, or autoimmune mechanisms in primary biliary cirrhosis, this antibody provides a dependable tool for signal transduction research across multiple validated applications.
Email: support@cusabio.com
Distributors Worldwide